企業プロフィール
10x Genomics 株価・ニュース・カタリスト
- ティッカー:
- TXG
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
57.99 USD (+3.39%)
終値
最終更新: 2026年8月17日
3.9B USD
時価総額
株価変動の要因
As of Aug 17, 2026, TXG closed up 3.39% at $57.99. No new same-company headline was identified in the current news window.
企業概要
事業概要
10x Genomics is a life sciences tools company focused on single-cell and spatial biology technologies. Its products help researchers study biology at high resolution and support discovery across genomics and translational research.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, 10x Genomics has a global footprint in research tools. It sits in the biotech infrastructure layer rather than therapeutics.
ビジネスモデルの特徴
The company generates revenue from instruments, consumables, and workflow technologies used in genomics research. Investors watch academic and biopharma spending, product adoption, and the pace of platform utilization.
バイオ業界での位置付け
10x Genomics is one of the most important tools names in modern biology because it powers discovery across the life sciences. It is not a drug company, but it is highly relevant to biotech research spending.
今後のカタリスト
- 10x Genomics’ catalysts are Xenium adoption, Chromium demand, and any evidence that consumables recovery is finally broadening. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。